|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Kappa- and delta-opioids block sympathetically dependent hyperalgesia.
|
2010815 |
1991 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia.
|
2128375 |
1990 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia.
|
3061568 |
1988 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.
|
7493622 |
1995 |
|
| Entrez Id: |
7124 |
| Gene Symbol: |
TNF |
TNF
|
0.320 |
Biomarker
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
3553 |
| Gene Symbol: |
IL1B |
IL1B
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
3569 |
| Gene Symbol: |
IL6 |
IL6
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
3586 |
| Gene Symbol: |
IL10 |
IL10
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
3586 |
| Gene Symbol: |
IL10 |
IL10
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
|
7582491 |
1995 |
|
| Entrez Id: |
7124 |
| Gene Symbol: |
TNF |
TNF
|
0.320 |
Biomarker
|
phenotype |
CTD_human |
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance.
|
7881729 |
1995 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance.
|
7881729 |
1995 |
|
| Entrez Id: |
3576 |
| Gene Symbol: |
CXCL8 |
CXCL8
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance.
|
7881729 |
1995 |
|
| Entrez Id: |
6863 |
| Gene Symbol: |
TAC1 |
TAC1
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.
|
8864563 |
1996 |
|
| Entrez Id: |
3557 |
| Gene Symbol: |
IL1RN |
IL1RN
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.
|
8864563 |
1996 |
|
| Entrez Id: |
3557 |
| Gene Symbol: |
IL1RN |
IL1RN
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.
|
8864563 |
1996 |
|
| Entrez Id: |
3479 |
| Gene Symbol: |
IGF1 |
IGF1
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice.
|
9452187 |
1997 |
|
| Entrez Id: |
551 |
| Gene Symbol: |
AVP |
AVP
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
The effect of noradrenaline, angiotensin II and vasopressin on blood flow and sensitivity to heat in capsaicin-treated skin.
|
9613798 |
1998 |
|
| Entrez Id: |
183 |
| Gene Symbol: |
AGT |
AGT
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
The effect of noradrenaline, angiotensin II and vasopressin on blood flow and sensitivity to heat in capsaicin-treated skin.
|
9613798 |
1998 |
|
| Entrez Id: |
6863 |
| Gene Symbol: |
TAC1 |
TAC1
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae).
|
9714424 |
1998 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae).
|
9714424 |
1998 |
|
| Entrez Id: |
3827 |
| Gene Symbol: |
KNG1 |
KNG1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
|
9720808 |
1998 |
|
| Entrez Id: |
7124 |
| Gene Symbol: |
TNF |
TNF
|
0.320 |
Biomarker
|
phenotype |
CTD_human |
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
|
10401557 |
1999 |
|
| Entrez Id: |
3553 |
| Gene Symbol: |
IL1B |
IL1B
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
|
10401557 |
1999 |
|
| Entrez Id: |
3569 |
| Gene Symbol: |
IL6 |
IL6
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
|
10401557 |
1999 |